Physician

Charu Gupta, MD

According to 2025 Medicare claims, Charu Gupta, MD (NPI: 1689834418) practices advanced heart failure and transplant cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60026-1301.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 343 traditional Medicare patients, billed 1,032 HCPCS/CPT codes, and received $98,281 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,023 prescription claims across 301 beneficiaries totaling $3,349,135 in drug costs, led by Vyndamax (Tafamidis). 2023 DME data shows 93 claims. Open Payments data shows 6 records totaling $158. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,956 to $98,281. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,296 to $3,349,135. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $0 to $3,119.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	25	31	$1,956
2016	51	61	$3,293
2017	177	756	$63,105
2018	303	1,210	$106,694
2019	346	1,571	$134,837
2020	301	1,224	$102,283
2021	339	1,353	$129,067
2022	326	1,128	$104,415
2023	279	826	$84,243
2024	343	1,032	$98,281

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	45	$15,296
2016	52	850	$22,917
2017	61	460	$20,038
2018	127	995	$92,068
2019	191	1,696	$262,609
2020	218	2,044	$998,939
2021	258	2,411	$1,469,128
2022	271	3,213	$1,636,521
2023	289	3,215	$2,139,478
2024	301	4,023	$3,349,135

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$263
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	53	$1,842
2023	N/R	93	$2,602
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	76	80	$146
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	121	176	$115
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	114	311	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	43	$78
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	129	151	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	47	1,530	$1,198,520
Entresto	Sacubitril/Valsartan	493	32,173	$681,016
Vyndaqel	Tafamidis Meglumine	13	570	$442,533
Jardiance	Empagliflozin	217	15,241	$289,565
Eliquis	Apixaban	235	14,334	$274,268

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$158	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charu Gupta, MD?

Tedicare shows public-source Medicare data for Charu Gupta, MD (NPI 1689834418), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charu Gupta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charu Gupta, MD?

Charu Gupta, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Charu Gupta, MD have Open Payments data?

Charu Gupta, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.